Hypothesis
Two large cancer cell line screens, GDSC and CCLE, would report consistent drug responses for the same drugs in the same cell lines, so either could be used to find biomarkers.
What failed
Gene expression agreed well between the two screens, but drug sensitivity was inconsistent for 8 of the 15 drugs tested in both, whichever statistic was used. Only 5 drugs showed moderate to good consistency.
Broken assumption
Large drug screens of the same cell lines give the same drug-response results.
Why
The drug-response measurements themselves differ between the two projects. The authors argue that drug-response assays need standardisation and validation.
From the published paper: Safikhani et al. F1000Research, 2017. ↗CC BY